By Amy Mek<\/p>\n\n\n\n The parallels between the bird flu \u2018vaccine\u2019 push and the COVID-19 \u2018vaccine\u2019 campaign reveal a coordinated effort to capitalize on health crises for profit and control<\/p>\n\n\n\n In a concerning development that echoes the recent COVID-19 \u201cvaccine\u201d saga, pharmaceutical giant Moderna has secured a whopping<\/a> $176 million from the U.S. government to fast-track the development of a new mRNA flu vaccine. This vaccine is purportedly designed to protect against both seasonal influenza and bird flu viruses currently circulating in the United States. As Moderna prepares to kick off clinical trials next year, working closely with the U.S. government\u2019s Biomedical Advanced Research and Development Authority (BARDA), questions arise about the true motives and implications of this massive investment.<\/p>\n\n\n\n The U.S. Department of Health and Human Services (HHS) has expressed \u201cserious concerns\u201d about a potential health crisis stemming from an avian flu outbreak. With the virus continuing to spread among mammals, there is a so-called \u201clooming threat\u201d of a new pandemic<\/a> \u201cif\u201d it manages to jump to humans. This scenario, as reported <\/a>by The Telegraph, has fueled the urgency behind the government\u2019s investment in Moderna\u2019s new gene therapy injection, marketed as a \u2018vaccine\u2019.<\/p>\n\n\n\n However, while globalists pretend to be trying to protect the public from this \u201clooming threat,\u201d their actions suggest a more sinister goal. The push for viruses to jump from mammals to humans could further harm farmers and lead to the destruction of animals that form a crucial part of the human diet. This would devastate traditional farming communities and pave the way for the promotion of lab-grown meat and bugs, aligning with the globalist agenda of controlling the food supply.<\/a> By undermining natural food sources, they aim to steer the population towards synthetic alternatives, thereby increasing their grip on what people consume and furthering their control over the masses.<\/p>\n\n\n\n This investment comes at a critical time for Moderna. In the first quarter of this year, the company reported a staggering billion-dollar loss, as the demand for coronavirus \u201cvaccines\u201d has nearly vanished. Moderna\u2019s revenue plummeted by 91 percent to a mere $167 million, a sharp contrast to the over $19 billion generated from COVID-19 shots in 2022. This financial downturn has led the company to seek new revenue streams, and the avian flu injections appears to be the next goldmine.<\/p>\n\n\n\n Moderna isn\u2019t the only player in this game. Reports suggest that the U.S. government is also in talks with Pfizer about developing an mRNA vaccine against the avian flu virus. Pfizer, another major beneficiary of the COVID-19 \u201cvaccine\u201d boom, is similarly on the lookout for new lucrative opportunities. The financial motivations behind these developments cannot be ignored, especially considering the immense profits both companies reaped from their COVID-19 injections.<\/p>\n\n\n\n![\"\"\/](\"https:\/\/rairfoundation.com\/wp-content\/uploads\/2024\/07\/GettyImages-1258268250-e1719935952684-1200x630.webp\")
<\/figure>\n\n\n\nGovernment\u2019s Growing Concerns<\/h5>\n\n\n\n
![\"\"](\"https:\/\/rairfoundation.com\/wp-content\/uploads\/2024\/07\/DALL\u00b7E-2024-07-06-14.43.41-A-powerful-high-resolution-image-depicting-a-syringe-filled-with-a-liquid-labeled-mRNA-Vaccine-casting-a-large-ominous-shadow-over-a-farm-with-trad-1024x1024.webp\")
<\/figure>\n\n\n\nModerna\u2019s Financial Woes<\/h5>\n\n\n\n
A New Goldmine for Vaccine Makers?<\/h5>\n\n\n\n
European Union\u2019s Involvement<\/h5>\n\n\n\n